SS
SLDB icon

SBI Securities’s Solid Biosciences SLDB Stock Holding History

SBI Securities’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.56K Sell
857
-20
-2% -$152 ﹤0.01% 1917
2026
Q1 		$6.31K Buy
877
+121
+16% +$777 ﹤0.01% 1932
2025
Q4 		$4.26K Sell
756
-8
-1% -$43 ﹤0.01% 2085
2025
Q3 		$4.71K Buy
764
+355
+87% +$2.08K ﹤0.01% 2071
2025
Q2 		$1.99K Sell
409
-132
-24% -$467 ﹤0.01% 2381
2025
Q1 		$2K Buy
541
+263
+95% +$1.13K ﹤0.01% 2290
2024
Q4 		$1.11K Buy
+278
New +$1.53K ﹤0.01% 2557

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's SLDB Position: Q2 2026 in Review

SBI Securities reduced its Solid Biosciences (SLDB) stake by 2.3% in Q2 2026, selling an estimated $152 and leaving 857 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

SBI Securities first reported a position in SLDB in Q4 2024 and has held it in 7 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • SBI Securities held 857 shares of Solid Biosciences worth $8.56K as of Q2 2026.
  • SBI Securities sold 20 Solid Biosciences shares in Q2 2026, an estimated $152.
  • Solid Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1917 holding.
  • SBI Securities first reported a position in Solid Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.